77 results
424B3
ATXI
Avenue Therapeutics Inc
2 Feb 24
Prospectus supplement
12:00am
Incentive Plan;
1,685,000 shares of Common Stock issuable upon the exercise of stock options with a weighted-average exercise price of $1.14 per share
DEF 14C
ATXI
Avenue Therapeutics Inc
29 Jan 24
Information statement
8:00am
pursuant to the Company’s 2015 Incentive Plan, and expanding our business through the acquisition of other businesses and other purposes. We anticipate … transactions;
our equity incentive plans;
strategic investments; and
other corporate purposes that have not yet been identified.
The board of directors
PRE 14C
96ohi13 ltuktokfi7y6
17 Jan 24
Preliminary information
5:05pm
424B4
6gujopyo
2 Nov 23
Prospectus supplement with pricing info
9:00am
8-K
EX-10.1
k6zy 6n4co89
5 Jul 23
Departure of Directors or Certain Officers
4:15pm
8-K
0ksjxhj0
5 Jul 23
Departure of Directors or Certain Officers
4:15pm
424B3
oruu8p 36ua4
28 Jun 23
Prospectus supplement
4:56pm
424B3
kflw4g9wsyqj age4
4 May 23
Prospectus supplement
4:30pm